All Stories

  1. Data from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  2. Data from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  3. Figure 1 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  4. Figure 1 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  5. Figure 2 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  6. Figure 2 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  7. Figure 3 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  8. Figure 3 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  9. Figure 4 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  10. Figure 4 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  11. Figure 5 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  12. Figure 5 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  13. Figure 6 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  14. Figure 6 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  15. Supplementary Table 1 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  16. Supplementary Table 1 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  17. Supplementary Table 2 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  18. Supplementary Table 2 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  19. Supplementary Table 3 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  20. Supplementary Table 3 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  21. Supplementary Table 4 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  22. Supplementary Table 4 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  23. Supplementary Table 5 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  24. Supplementary Table 5 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  25. Supplementary figures from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  26. Supplementary figures from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  27. Supplementary legends from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  28. Supplementary legends from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  29. Supplementary notes from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  30. Supplementary notes from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  31. Table 1 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  32. Table 1 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  33. Data from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  34. Supplementary Table 1 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  35. Supplementary Table 1 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  36. Supplementary Table 2 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  37. Supplementary Table 2 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  38. Supplementary Table 3 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  39. Supplementary Table 3 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  40. Supplementary Table 4 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  41. Supplementary Table 4 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  42. Supplementary Table 5 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  43. Supplementary Table 5 from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  44. Supplementary figures from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  45. Supplementary figures from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  46. Supplementary legends from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  47. Supplementary legends from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  48. Supplementary notes from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  49. Supplementary notes from The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  50. The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
  51. Implementation of Personalized Medicine by Artificial Intelligence Platform
  52. Shedding Light on the Dark Web: Authorship Attribution in Radical Forums
  53. KERMITviz: Visualizing Neural Network Activations on Syntactic Trees
  54. Dis-Cover AI Minds to Preserve Human Knowledge
  55. Discover AI Knowledge to Preserve Cultural Heritage
  56. Data Augmentation Using Background Replacement for Automated Sorting of Littered Waste
  57. Towards the Interpretability of Machine Learning Predictions for Medical Applications Targeting Personalised Therapies: A Cancer Case Survey
  58. Pat-in-the-Loop: Declarative Knowledge for Controlling Neural Networks
  59. CYK Parsing over Distributed Representations
  60. Breast Cancer Prognosis Using a Machine Learning Approach
  61. Viewpoint: Human-in-the-loop Artificial Intelligence
  62. Predicting VTE in Cancer Patients: Candidate Biomarkers and Risk Assessment Models
  63. Artificial intelligence for cancer-associated thrombosis risk assessment
  64. Have You Lost the Thread? Discovering Ongoing Conversations in Scattered Dialog Blocks
  65. Can we explain natural language inference decisions taken with neural networks? Inference rules in distributed representations
  66. Validation of a Machine Learning Approach for Venous Thromboembolism Risk Prediction in Oncology
  67. RISK: A Random Optimization Interactive System Based on Kernel Learning for Predicting Breast Cancer Disease Progression
  68. Risk Assessment for Venous Thromboembolism in Chemotherapy-Treated Ambulatory Cancer Patients
  69. When the Whole Is Not Greater Than the Combination of Its Parts: A “Decompositional” Look at Compositional Distributional Semantics
  70. Decoding Distributed Tree Structures
  71. Linear Online Learning over Structured Data with Distributed Tree Kernels
  72. Recognizing Textual Entailment: Models and Applications
  73. Travel with Words: An Innovative Vision on Travelling
  74. Parallels between Machine and Brain Decoding
  75. Brain Informatics
  76. Reading What Machines "Think": A Challenge for Nanotechnology
  77. Efficient Graph Kernels for Textual Entailment Recognition
  78. Inductive probabilistic taxonomy learning using singular value decomposition
  79. Transitivity in semantic relation learning
  80. Comparing EEG/ERP-Like and fMRI-Like Techniques for Reading Machine Thoughts
  81. A machine learning approach to textual entailment recognition
  82. Probabilistic Ontology Learner in Semantic Turkey
  83. Reading What Machines “Think”
  84. Natural Language Processing Across Time: An Empirical Investigation on Italian
  85. Fast and effective kernels for relational learning from texts
  86. Learning Textual Entailment on a Distance Feature Space
  87. Discovering Verb Relations in Corpora: Distributional Versus Non-distributional Approaches
  88. A Linguistic Inspection of Textual Entailment
  89. Personalizing Web publishing via information extraction
  90. Parsing engineering and empirical robustness
  91. Exploiting Transitivity in Probabilistic Models for Ontology Learning
  92. Understanding the Web through its Language
  93. Integrating ontological and linguistic knowledge for conceptual information extraction
  94. Web-based information access: multilingual automatic authoring